Rawashdeh Badi, AlRyalat Saif Aldeen, Rawshdeh Aasem, Abuassi Mohammad, Al-Mansour Zeina, El-Hinnawi Ashraf
Division of Transplant Surgery, Department of General Surgery, Medical College of Wisconsin, Milwaukee, WI.
Faculty of Medicine, Jordan University.
Ann Med Surg (Lond). 2024 Feb 5;86(3):1522-1530. doi: 10.1097/MS9.0000000000001771. eCollection 2024 Mar.
Post-transplant lymphoproliferative diseases (PTLD) are a heterogeneous collection of neoplasms that occur after solid organ transplants (SOT). In the past 20 years, there has been a rise in PTLD research. This study aims to investigate the global research output and interest regarding PTLD using a bibliometric approach.
On 28 November 2022, the Web of Science Core Collection documents on PTLD published between 2000 and 2022 were collected and analyzed using bibliometric techniques. The VOSviewer application was utilized to visualize the annual number of publications, authors, organizations, countries, published journals, citations, and most occurring keywords.
A total of 2814 documents were retrieved, and a screening process included 1809 documents. The total number of citations was 45 239, and the average number per item was 25. Most articles ( = 747) and citations ( = 25 740) were produced in the United States. Based on citations, most of the top 10 institutions that contributed were in the United States of America. The University of Pittsburgh topped the list with 2700 citations and 64 articles. The vast majority of articles were published in Pediatric Transplantation ( = 147), Transplantation ( = 124), and the American Journal of Transplantation ( = 98). Transplantation has received the most citations, 6499, followed by the American Journal of Transplantation with 5958 citations and Blood with 4107 citations.
With ongoing debates over optimal classification, Epstein-Bar virus involvement, and treatment, this topic has received significant interest from researchers in recent years. Our results can be used as a guide for future research in the field and as a framework for a more in-depth look at the scientific progress of PTLD.
移植后淋巴增生性疾病（PTLD）是实体器官移植（SOT）后发生的一组异质性肿瘤。在过去20年中，PTLD研究有所增加。本研究旨在采用文献计量学方法调查全球关于PTLD的研究产出和关注度。
2022年11月28日，收集了科学网核心合集中2000年至2022年发表的关于PTLD的文献，并使用文献计量学技术进行分析。利用VOSviewer应用程序可视化年度出版物数量、作者、组织、国家、发表期刊、引用次数和出现频率最高的关键词。
共检索到2814篇文献，筛选过程纳入1809篇文献。总引用次数为45239次，平均每篇文献25次。大多数文章（n = 747）和引用（n = 25740）来自美国。基于引用次数，贡献最大的前10所机构大多在美国。匹兹堡大学以2700次引用和64篇文章位居榜首。绝大多数文章发表在《儿科移植》（n = 147）、《移植》（n = 124）和《美国移植杂志》（n = 98）上。《移植》获得的引用次数最多，为6499次，其次是《美国移植杂志》，为5958次，《血液》为4107次。
随着对最佳分类、爱泼斯坦-巴尔病毒感染和治疗的持续争论，该主题近年来受到了研究人员的极大关注。我们的结果可作为该领域未来研究的指南，以及更深入了解PTLD科学进展的框架。
